Detail page

Knowledge Web

Person

Christopher Nelke (1991-)

Arzt

Name	Christopher Nelke
Time	1991- (Date of birth and death)
Place	Eckernförde (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Related	Universitätsklinikum Düsseldorf Neurologie (Thema)
Record type	Person
GND-Identifier	1204280029
Record ID	1204280029
Involved in show all Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis Bilateral vocal cord palsy as complication of CNS tuberculosis The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims Data Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019 Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells Inclusion body myositis and associated diseases: an argument for shared immune pathologies Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients Neonatal Fc Receptor–Targeted Therapies in Neurology A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies Eculizumab versus rituximab in generalised myasthenia gravis Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis Keine verbesserte Muskelkraft mit Sirolimus Antikörper gegen den neonatalen FC-Rezeptor auf dem Prüfstand bei Myasthenia gravis The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD Der Einfluss AICD abhängiger Lipidveränderungen auf die APP-Prozessierung und die mögliche Implikation der Methylxanthine bei der Alzheimer Erkrankung Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells : Consequences for Alzheimer’s Disease

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christopher Nelke (1991-)

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis

Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment

Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases

Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis

Bilateral vocal cord palsy as complication of CNS tuberculosis

The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation

Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims Data

Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation

Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls

Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019

Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis

Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells

Inclusion body myositis and associated diseases: an argument for shared immune pathologies

Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

Neonatal Fc Receptor–Targeted Therapies in Neurology

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies

Eculizumab versus rituximab in generalised myasthenia gravis

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Keine verbesserte Muskelkraft mit Sirolimus

Antikörper gegen den neonatalen FC-Rezeptor auf dem Prüfstand bei Myasthenia gravis

The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome

An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD

Der Einfluss AICD abhängiger Lipidveränderungen auf die APP-Prozessierung und die mögliche Implikation der Methylxanthine bei der Alzheimer Erkrankung

Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells

Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells : Consequences for Alzheimer’s Disease